Akira Takazawa

2PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 16, 2022
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).

Morihito Okada, Ken Kato, Byoung Chul Cho

|Sep 02, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata

Pageof 1

Frequent Collaborators

1 joint publications

Junzo Hamanishi

1 joint publications

Satoshi Takeuchi

1 joint publications

Koji Matsumoto

1 joint publications

Kimihiko Ito